Abstract:In cells of the myeloid lineage, NLRP3 stimulation leads to disassembly of the trans‐Golgi network (TGN). The resulting dispersed TGN serves as a scaffold for NLRP3 aggregation, leading to cytokine production and pyroptosis. In contrast, it is proposed that the magnitude of interactions between the polybasic motif of NLRP3 and the TGN in adaptive immunity is low, which triggers cytokine production, but does not result in pyroptotic cell death. Eukaryotic cells are equipped with cytoplasmic sensors that recognize diverse pathogen‐ or danger‐associated molecular patterns. In cells of the myeloid lineage, activation of these sensors leads to the assembly of a multimeric protein complex, called the inflammasome, that culminates in the production of inflammatory cytokines and pyroptosis. Recently, investigation of the inflammasomes in lymphocytes led to the discovery of functional pathways that were initially believed to be confined to the innate arm of the immune system. Thus, the adapter protein apoptosis‐associated speck‐like protein containing a CARD (ASC) was documented to play a critical role in antigen uptake by dendritic cells, and regulation of T‐ and B‐cell motility at several stages, and absent in melanoma 2 (AIM2) was found to act as a modulator of regulatory T‐cell differentiation. Remarkably, NLRP3 was demonstrated to act as a transcription factor that controls Th2 cell polarization, and as a negative regulator of regulatory T‐cell differentiation by limiting Foxp3 expression. In B lymphocytes, NLRP3 plays a role in the transcriptional network that regulates B‐cell development and homing, and its activation is essential for germinal center formation and maturation of high‐affinity antibody responses. Such recently discovered inflammasome‐mediated functions in T and B lymphocytes offer multiple cross‐talk opportunities for the innate and adaptive arms of the immune system. A better understanding of the dialog between inflammasomes and intracellular components could be beneficial for therapeutic purposes in restoring immune homeostasis and mitigating inflammation in a wide range of disorders.

A novel “complement–metabolism–inflammasome axis” as a key regulator of immune cell effector function

Activation and Pharmacological Regulation of Inflammasomes

Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases

Complement membrane attack complex is an immunometabolic regulator of NLRP3 activation and IL-18 secretion in human macrophages

Metabolic regulation of inflammasomes in inflammation

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Inflammasome activation: from molecular mechanisms to autoinflammation

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Swaying the advantage: multifaceted functions of inflammasomes in adaptive immunity

From fat to fire: The lipid–inflammasome connection

Focus on the Role of NLRP3 Inflammasome in Diseases

How Inflammasomes Inform Adaptive Immunity

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation

How location and cellular signaling combine to activate the NLRP3 inflammasome

Complement-Mediated Regulation of Metabolism and Basic Cellular Processes

Metabolic Regulation of the NLRP3 Inflammasome

Enigmatic inflammasomes

The NLRP3 Inflammasome: Role in Metabolic Disorders and Regulation by Metabolic Pathways

Post-translational control of NLRP3 inflammasome signaling